US Stock MarketDetailed Quotes

Prime Medicine (PRME)

Watchlist
  • 2.710
  • -0.170-5.90%
Close Jun 10 15:59 ET
  • 2.760
  • +0.050+1.85%
Post 19:45 ET
489.47MMarket Cap-2.20P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Prime Medicine (PRME) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-41.13%856K
55.28%4.63M
-61.61%838K
486.12%1.23M
1.12M
146.02%1.45M
2.98M
2.18M
209K
0
Operating revenue
-41.13%856K
55.28%4.63M
-61.61%838K
486.12%1.23M
--1.12M
146.02%1.45M
--2.98M
--2.18M
--209K
--0
Cost of revenue
Gross profit
Operating expense
-4.34%51.51M
3.67%212.98M
6.55%49.45M
1.39%55.2M
-2.12%54.49M
10.04%53.85M
7.40%205.45M
-14.92%46.41M
5.79%54.44M
23.01%55.67M
Selling and administrative expenses
31.02%17.41M
4.36%52.35M
19.80%14.74M
-20.52%11.21M
4.09%13.12M
19.05%13.28M
15.61%50.16M
-5.98%12.3M
34.38%14.1M
18.23%12.6M
-General and administrative expense
31.02%17.41M
4.36%52.35M
19.80%14.74M
-20.52%11.21M
4.09%13.12M
19.05%13.28M
15.61%50.16M
-5.98%12.3M
34.38%14.1M
18.23%12.6M
Research and development costs
-15.92%34.11M
3.44%160.64M
1.77%34.71M
9.05%43.99M
-3.94%41.38M
7.38%40.56M
4.99%155.29M
-17.74%34.1M
-1.53%40.34M
24.49%43.07M
Operating profit
3.32%-50.65M
-2.91%-208.35M
-9.92%-48.61M
0.48%-53.97M
4.12%-53.38M
-8.38%-52.39M
-5.84%-202.47M
18.92%-44.22M
-5.39%-54.23M
-23.01%-55.67M
Net non-operating interest income expense
-13.62%1.02M
17.80%4.15M
-29.58%1.08M
63.70%1.14M
21.60%743K
74.85%1.18M
25.29%3.52M
213.24%1.54M
70.00%697K
-3.78%611K
Non-operating interest income
-13.62%1.02M
17.80%4.15M
-29.58%1.08M
63.70%1.14M
21.60%743K
74.85%1.18M
25.29%3.52M
213.24%1.54M
70.00%697K
-3.78%611K
Other net income (expense)
175.15%511K
-0.13%3.06M
254.41%1.45M
121.24%2.25M
110.75%43K
-133.37%-680K
130.84%3.06M
103.52%408K
336.48%1.02M
-117.64%-400K
Gain on sale of security
----
189.07%432K
813.56%539K
576.28%1.45M
73.77%-505K
-190.57%-1.06M
79.64%-485K
-90.71%59K
113.62%215K
-831.94%-1.93M
Special income (charges)
----
----
----
----
----
----
--0
----
----
----
Other non- operating income (expenses)
37.84%51K
260.98%148K
13.95%49K
153.01%44K
-53.85%18K
-11.90%37K
-85.04%41K
-70.95%43K
-293.02%-83K
-4.88%39K
Income before tax
5.33%-49.12M
-2.69%-201.14M
-9.00%-46.08M
3.69%-50.58M
5.17%-52.59M
-13.73%-51.89M
1.28%-195.88M
35.60%-42.28M
-3.35%-52.52M
-30.95%-55.46M
Income tax
0
0
0
0
0
-532.26%-134K
Net income
5.33%-49.12M
-2.69%-201.14M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
Net income continuous Operations
5.33%-49.12M
-2.69%-201.14M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
Minority interest income
Net income attributable to the parent company
5.33%-49.12M
-2.69%-201.14M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.33%-49.12M
-2.69%-201.14M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
1.14%-195.88M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
Basic earnings per share
30.00%-0.28
18.18%-1.35
22.58%-0.24
27.27%-0.32
10.87%-0.41
9.09%-0.4
24.31%-1.65
56.94%-0.31
20.00%-0.44
2.13%-0.46
Diluted earnings per share
30.00%-0.28
18.18%-1.35
22.58%-0.24
27.27%-0.32
10.87%-0.41
9.09%-0.4
24.31%-1.65
56.94%-0.31
20.00%-0.44
2.13%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -41.13%856K55.28%4.63M-61.61%838K486.12%1.23M1.12M146.02%1.45M2.98M2.18M209K0
Operating revenue -41.13%856K55.28%4.63M-61.61%838K486.12%1.23M--1.12M146.02%1.45M--2.98M--2.18M--209K--0
Cost of revenue
Gross profit
Operating expense -4.34%51.51M3.67%212.98M6.55%49.45M1.39%55.2M-2.12%54.49M10.04%53.85M7.40%205.45M-14.92%46.41M5.79%54.44M23.01%55.67M
Selling and administrative expenses 31.02%17.41M4.36%52.35M19.80%14.74M-20.52%11.21M4.09%13.12M19.05%13.28M15.61%50.16M-5.98%12.3M34.38%14.1M18.23%12.6M
-General and administrative expense 31.02%17.41M4.36%52.35M19.80%14.74M-20.52%11.21M4.09%13.12M19.05%13.28M15.61%50.16M-5.98%12.3M34.38%14.1M18.23%12.6M
Research and development costs -15.92%34.11M3.44%160.64M1.77%34.71M9.05%43.99M-3.94%41.38M7.38%40.56M4.99%155.29M-17.74%34.1M-1.53%40.34M24.49%43.07M
Operating profit 3.32%-50.65M-2.91%-208.35M-9.92%-48.61M0.48%-53.97M4.12%-53.38M-8.38%-52.39M-5.84%-202.47M18.92%-44.22M-5.39%-54.23M-23.01%-55.67M
Net non-operating interest income expense -13.62%1.02M17.80%4.15M-29.58%1.08M63.70%1.14M21.60%743K74.85%1.18M25.29%3.52M213.24%1.54M70.00%697K-3.78%611K
Non-operating interest income -13.62%1.02M17.80%4.15M-29.58%1.08M63.70%1.14M21.60%743K74.85%1.18M25.29%3.52M213.24%1.54M70.00%697K-3.78%611K
Other net income (expense) 175.15%511K-0.13%3.06M254.41%1.45M121.24%2.25M110.75%43K-133.37%-680K130.84%3.06M103.52%408K336.48%1.02M-117.64%-400K
Gain on sale of security ----189.07%432K813.56%539K576.28%1.45M73.77%-505K-190.57%-1.06M79.64%-485K-90.71%59K113.62%215K-831.94%-1.93M
Special income (charges) --------------------------0------------
Other non- operating income (expenses) 37.84%51K260.98%148K13.95%49K153.01%44K-53.85%18K-11.90%37K-85.04%41K-70.95%43K-293.02%-83K-4.88%39K
Income before tax 5.33%-49.12M-2.69%-201.14M-9.00%-46.08M3.69%-50.58M5.17%-52.59M-13.73%-51.89M1.28%-195.88M35.60%-42.28M-3.35%-52.52M-30.95%-55.46M
Income tax 00000-532.26%-134K
Net income 5.33%-49.12M-2.69%-201.14M-9.00%-46.08M3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M
Net income continuous Operations 5.33%-49.12M-2.69%-201.14M-9.00%-46.08M3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M
Minority interest income
Net income attributable to the parent company 5.33%-49.12M-2.69%-201.14M-9.00%-46.08M3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.33%-49.12M-2.69%-201.14M-9.00%-46.08M3.69%-50.58M4.95%-52.59M-13.39%-51.89M1.14%-195.88M35.60%-42.28M-3.57%-52.52M-30.53%-55.33M
Basic earnings per share 30.00%-0.2818.18%-1.3522.58%-0.2427.27%-0.3210.87%-0.419.09%-0.424.31%-1.6556.94%-0.3120.00%-0.442.13%-0.46
Diluted earnings per share 30.00%-0.2818.18%-1.3522.58%-0.2427.27%-0.3210.87%-0.419.09%-0.424.31%-1.6556.94%-0.3120.00%-0.442.13%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.23%
Sample Name
Sample Code
 +1.31%
Sample Name
Sample Code
 -1.03%
4
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-2.32%
5
ProShares UltraShort Energy
DUG
-2.99%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +2.95%
Sample Name
Sample Code
 +1.98%
Sample Name
Sample Code
 +1.29%
4
Tencent Music
TME
+0.77%
5
Zai Lab
ZLAB
+0.52%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Tensions in the Middle East continue to escalate. After Iran shot down a U.S. Apache helicopter, the U.S. military launched retaliatory airs Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -